We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly Submitting sNDA for Cymbalta to Treat Fibromyalgia
Eli Lilly Submitting sNDA for Cymbalta to Treat Fibromyalgia
August 24, 2007
Eli Lilly has submitted a supplemental new drug application (sNDA) to the FDA for its antidepressant Cymbalta to manage fibromyalgia, the company announced.